Dravet syndrome (severe myoclonic epilepsy in infancy)

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 627-633

  Dravet, Charlotte ^a   Oguni, Hirokazu ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876815848     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00065-8     Document Type: Chapter

References (81)

1. Akiyama M., Kobayashi K., Yoshinaga H., et al. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010, 51:1043-1052.
2. Awaya Y., Satoh F., Miyamoto M., et al. Change of rectal temperature in infants and children during and after hot water immersion. Clinical Thermometry (Tokyo) 1989, 9:76-82.
3. Black A., Baker M. The impact of parent advocacy groups, the Internet, and social networking on rare diseases: The IDEA League and IDEA League United Kingdom example. Epilepsia 2011, 52(Suppl. 2):102-104.
4. Capovilla G., Beccaria F., Romeo A., et al. Effectiveness of a particular blue lens on photoparoxysmal response in photosensitive epileptic patients. Ital J Neurol Sci 1999, 20:161-166.
5. Caraballo R.H. Non pharmacological treatments of Dravet syndrome: focus on ketogenic diet. Epilepsia 2011, 52(Suppl. 2):79-82.
6. Ceulemans B.P., Claes L.R., Lagae L.G. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy. Pediatr Neurol 2004, 30:236-243.
7. Chipaux M., Villeneuve N., Sabouraud P., et al. Unusual consequences of status epilepticus in Dravet syndrome. Seizure 2010, 19:190-194.
8. Chiron C., Marchand M.C., Tran A., et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000, 356:1638-1642.
9. Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
10. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:289-299.
11. Coppola G., Capovilla G., Montagnini A., et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 2002, 49:45-48.
12. Depienne C., Trouillard O., Saint-Martin C., et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 2009, 46:183-191.
13. Depienne C., Bouteiller D., Keren B., et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009, 5:e1000381.
14. Doose H., Lunau H., Castiglione E., et al. Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 1998, 2:229-238.
15. Dravet C. Les épilepsies graves de l'enfant. Vie Med 1978, 8:543-548.
16. Dravet C., Bureau M., Guerrini R., et al. Severe myoclonic epilepsy in infants. Epileptic Syndromes in Infancy, Childhood and Adolescence 1992, 75-88. John Libbey, London. 2nd edn. J. Roger, C. Dravet, M. Bureau (Eds.).
17. Dravet C., Bureau M., Oguni H., et al. Severe myoclonic epilepsy in infancy (Dravet syndrome). Epileptic Syndromes in Infancy, Childhood and Adolescence 2005, 89-113. John Libbey Eurotext Ltd, London. 4th edn. J. Roger, M. Bureau, C. Dravet (Eds.).
18. Dravet C., Daquin G., Battaglia D. Severe myoclonic epilepsy of infancy (Dravet syndrome). Long-term Evolution of Epileptic Encephalopathies 2009, 29-38. John Libbey Eurotext Ltd, Paris. M. Nikanorova, P. Genton, A. Sabers (Eds.).
19. Durà-Travé T., Yoldi-Petri M.E., Gallinas-Victoriano F. Epilepsy in children in Navarre, Spain: epileptic seizures and epileptic syndromes. J Child Neurol 2007, 22:823-828.
20. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy. Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
21. Fejerman N., Caraballo R., Cersosimo R., et al. Ketogenic diet in patients with Dravet syndrome and myoclonic epilepsies in infancy and early childhood. Advances in Neurology, vol 95: Myoclonic Epilepsies 2005, 299-305. Lippincott Williams & Wilkins, Philadelphia. V. Delgado-Escueta, R. Guerrini, M.T. Medina (Eds.).
22. Fujiwara T., Nakamura H., Watanabe M., et al. Clinicoelectrographic concordance between monozygotic twins with severe myoclonic epilepsy in infancy. Epilepsia 1990, 31:281-286.
23. Fujiwara T., Sugawara T., Mazaki-Miyazaki E., et al. Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic clonic seizures. Brain 2003, 126:531-546.
24. Fukuma G., Oguni H., Shirasaka Y., et al. Mutations of neuronal voltage-gated Na+ channel α 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia 2004, 45:140-148.
25. Gennaro E., Veggiotti P., Malacarne M., et al. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord 2003, 5:21-25.
26. Gennaro E., Santorelli F.M., Bertini E., et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun 2006, 341:489-493.
27. Granata T. Comprehensive care of children with Dravet syndrome. Epilepsia 2011, 52(Suppl. 2):90-94.
28. Guerrini R., Dravet C. Severe epileptic encephalopathies of infancy, other than West syndrome. Epilepsy. A Comprehensive Textbook 1998, Vol. 3:2285-2302. Lippincott-Raven, Philadelphia/New York. J. Engel, T.A. Pedley (Eds.).
29. Guerrini R., Dravet C., Genton P., et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998, 39:508-512.
30. Guerrini R., Parmeggiani L., Bonanni P., et al. Myoclonic astatic epilepsy. Epileptic Syndromes in Infancy, Childhood and Adolescence 2005, 115-124. John Libbey Eurotext Ltd, London. 4th edn. J. Roger, M. Bureau, C. Dravet (Eds.).
31. Guerrini R., Cellini E., Mei D., et al. Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene. Epilepsia 2010, 51:2474-2477.
32. A-Receptor γ 2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002, 70:530-536.
33. Hattori J., Ouchida M., Ono J., et al. A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 2008, 49:626-633.
34. Heron S.E., Scheffer I.E., Iona X., et al. De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin. J Med Genet 2010, 47:137-141.
35. Hurst D.L. Severe myoclonic epilepsy in infancy. Pediatr Neurol 1987, 3:269-272.
36. Hurst D.L. Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 1990, 31:397-400.
37. Jansen F.E., Sadleir L.G., Harkin L.A., et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006, 67:2224-2226.
38. Kimura K., Sugawara T., Mazaki-Miyazaki E., et al. A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures. Brain Dev 2005, 27:424-430.
39. Lossin C. A catalog of SCN1A variants. Brain Dev 2009, 31:114-130.
40. Madia F., Gennaro E., Cecconi M., et al. No evidence of GABRG2 mutations in severe myoclonic epilepsy of infancy. Epilepsy Res 2003, 53:196-200.
41. Madia F., Striano P., Gennaro E., et al. Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology 2006, 67:1230-1235.
42. Marini C., Mei D., Parmeggiani L., et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 2010, 75:646-653.
43. Miyama S., Goto T., Inoue Y., et al. Monozygotic twins with severe myoclonic epilepsy in infancy discordant for clinical features. Pediatr Neurol 2008, 39:120-122.
44. Morimoto M., Mazaki E., Nishimura A., et al. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 2006, 47:1732-1736.
45. Mulley J.C., Nelson P., Guerrero S., et al. A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 2006, 67:1094-1095.
46. Nabbout R., Gennaro E., Dalla Bernardina B., et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 2003, 60:1961-1967.
47. Nabbout R., Desguerre I., Sabbagh S., et al. An unexpected EEG course in Dravet syndrome. Epilepsy Res 2008, 81:90-95.
48. Nakayama T., Ogiwara I., Ito K., et al. Deletions of SCN1A 5' genomic region with promoter activity in Dravet syndrome. Hum Mutat 2010, 31:820-829.
49. Oakley J.C., Kalume F., Yu F.H., et al. Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. Proc Natl Acad Sci U S A 2009, 106:3994-3999.
50. Ogino T., Ohtsuka Y., Yamatogi Y., et al. The epileptic syndrome sharing common characteristics during early childhood with severe myoclonic epilepsy of infancy. Jpn J Psychiatry Neurol 1989, 43:479-481.
51. Ogiwara I., Miyamoto H., Morita N., et al. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007, 27:5903-5914.
52. Oguni H., Kitami H., Oguni M., et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994, 35:1140-1145.
53. Oguni H., Hayashi K., Awaya Y., et al. Severe myoclonic epilepsy in infants: a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev 2001, 23:736-748.
54. Oguni H., Hayashi K., Osawa M., et al. Severe myoclonic epilepsy in infants. Typical and borderline groups in relation to SCN1A mutations. Advances in Neurology, vol 95: Myoclonic Epilepsies 2005, 103-117. Lippincott Williams & Wilkins, Philadelphia. A.V. Delgado-Escueta, R. Guerrini (Eds.).
55. Ohki T., Watanabe K., Negoro K., et al. Severe myoclonic epilepsy in infancy: evolution of seizures. Seizure 1997, 6:219-224.
56. Ohmori I., Ouchida M., Ohtsuka Y., et al. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun 2002, 295:17-23.
57. Ohmori I., Ohtsuka Y., Ouchida M., et al. Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations?. Brain Dev 2003, 27:488-493.
58. Ohtsuka Y., Maniwa S., Ogino T., et al. Severe myoclonic epilepsy in infancy: a long-term follow-up study. Jpn J Psychiatry Neurol 1991, 45:416-418.
59. Okumura A., Kurahashi H., Hirose S., et al. Focal epilepsy resulting from a de novo SCN1A mutation. Neuropediatrics 2007, 38:253-256.
60. Patino G.A., Claes L.R., Lopez-Santiago L.F., et al. A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci 2009, 29:10764-10778.
61. Ragona F., Granata T., Dalla Bernardina B., et al. Cognitive development in Dravet syndrome: a retrospective, multi center study of 26 patients. Epilepsia 2011, 52:386-392.
62. Renier W.O., Renkawek K. Clinical and neuropathologic findings in a case of severe myoclonic epilepsy of infancy. Epilepsia 1990, 31:287-291.
63. Sakauchi M., Oguni H., Kato I., et al. Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epilepsia 2011, 52(Suppl. 2):50-54.
64. Sarisjulis N., Gamboni B., Plouin P., et al. Diagnosing idiopathic/cryptogenic epilepsy syndromes in infancy. Arch Dis Child 2000, 82:226-230.
65. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120:479-490.
66. Scheffer I.E., Turner S.J., Dibbens L.M., et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008, 131:900-901.
67. Siegler Z., Barsi P., Neuwirth M., et al. Hippocampal sclerosis in severe myoclonic epilepsy in infancy: a retrospective MRI study. Epilepsia 2005, 46:704-708.
68. Singh R., Andermann E., Whitehouse W.P., et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+?. Epilepsia 2001, 42:837-844.
69. Singh N.A., Pappas C., Dahle E.J., et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet 2009, 5:e1000649.
70. Striano P., Mancardi M., Biancheri R., et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia 2007, 48:1092-1096.
71. Striano P., Coppola A., Pezzella M., et al. An open-label trial of Levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007, 69:250-254.
72. Sugawara T., Mazaki-Miyazaki E., Fukushima K., et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002, 58:1122-1124.
73. Suls A., Velizarova R., Yordanova I., et al. Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene. Neurology 2010, 75:72-76.
74. Takahashi T., Tsukahara Y. Usefulness of blue sunglasses in photosensitive epilepsy. Epilepsia 1992, 33:517-521.
75. Vadlamudi L., Dibbens L.M., Lawrence K.M., et al. Timing of de novo mutagenesis: a twin study of sodium-channel mutations. N Engl J Med 2010, 363:1335-1340.
76. Wallace R.H., Scheffer I.E., Barnett S., et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001, 68:859-865.
77. Wallace R.H., Hodgson B.L., Grinton B.E., et al. Sodium channel α 1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 2003, 61:765-769.
78. Wolff M., Cassé-Perrot C., Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006, 47:45-48.
79. Yakoub M., Dulac O., Jambaque I., et al. Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 1992, 14:299-303.
80. Yu F.H., Mantegazza M., Westenbroek R.E., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9:1142-1149.
81. Zuberi S.M., Brunklaus A., Birch R., et al. Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 2011, 76:594-600.